Pfizer Plans to Ask Regulators for COVID-19 Vaccine Authorization for Young Children in October

Pfizer Plans to Ask Regulators for COVID-19 Vaccine Authorization for Young Children in October
Syringes and vials of the Pfizer-BioNTech COVID-19 vaccine are prepared to be administered to front-line health care workers under an emergency use authorization at a drive up vaccination site from Renown Health in Reno, Nev. on Dec. 17, 2020. Patrick T. Fallon/AFP via Getty Images
Zachary Stieber
By Zachary Stieber, Senior Reporter
Updated:

Pfizer is eying an October submission of safety and efficacy data for its COVID-19 vaccine to U.S. drug regulators in a bid to gain authorization for shots for children between the ages of 5 and 11, two company officials said Tuesday.

Pfizer’s COVID-19 vaccine, made with German partner BioNTech, is currently only authorized for emergency use in the United States for those 12 to 15, with approval granted last month for Americans 16 and older.
Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics